Core Viewpoint - The company is actively monitoring global infectious disease prevention and antiviral drug research needs, providing non-clinical research technical support to domestic and internationally positioned clients, with steady progress in various collaborative projects [1] Group 1: Company Operations - Non-clinical research and bioanalysis services are crucial components of the company's pharmaceutical service segment, which has maintained steady growth driven by the demand for innovative drug development [1] - The company aims to continuously strengthen its technical capabilities to promote the long-term stable development of its pharmaceutical service business [1]